The effects of vitamin D3 supplementation on some of metabolic and inflammatory markers in patients with diabetic nephropathy

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•aged between 20 to 50 years; have type 2 diabetes; control blood glucose less than 140 mg / dl; With BMI 20-35; stage 3 nad 4 diabetic nephropathy; albuminuria more than 30 mg per day; lack of proven vitamin D levels over 15 ng / l and less than 30 ng / l; Do not use calcium supplements and vitamin D in the last 3 months; Not taking medications that affect vitamin D metabolism, such as parathyroid hormone, estrogen, and calcitonin; willingness to cooperate
•Exclusion criteria:
•Changing the dose of the blood glucose lowering drugs; Change of medication or other treatment; taking calcium and vitamin D supplements during the study; with glomerulonephritis; Phosphorus more than 2/5 mg / dl; corrected calcium more than 10 mg / dl; active malignancy; The possibility of requiring renal replacement over the next year; uncontrolled high blood pressure; Taking antacids containing magnesium; Thiazide diuretics consumption; unwillingness to participate or to continue working

发起方

Vice chancellor for research, Tabriz University of Medical Sciences